| Erin E Gustafson, MS, CCC-SLP | |
|
2174 N Druid Hills Rd Ne, Atlanta, GA 30329-3102 | |
| (404) 785-7022 | |
| Not Available |
| Full Name | Erin E Gustafson |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2174 N Druid Hills Rd Ne, Atlanta, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013586940 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SLP011581 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Erin E Gustafson, MS, CCC-SLP 476 Wilmer St Ne Unit 1537, Atlanta, GA 30308-2956 Ph: (770) 841-8196 | Erin E Gustafson, MS, CCC-SLP 2174 N Druid Hills Rd Ne, Atlanta, GA 30329-3102 Ph: (404) 785-7022 |
News Archive
The brain has billions of neurons, arranged in complex circuits that allow us to perceive the world, control our movements and make decisions. Deciphering those circuits is critical to understanding how the brain works and what goes wrong in neurological disorders.
Researchers of the Labpsictec at the Universitat Jaume I of Castellon and the LahHuman Group at the Universidad Politecnica of Valencia and the University of Valencia have developed a new therapy based on the use of mobile devices and virtual reality for the psychological treatment of patients suffering from fibromyalgia.
Cervical cancer rates in the United States are higher than previously believed, particularly among 65- to 69-year-old women and African-American women, according to a study led by a researcher at the University of Maryland School of Medicine published in the journal Cancer.
Pfizer Oncology announced today that it will present new data from the company's pipeline, including two novel, dual PI3K/mTOR inhibitors (PF-04691502 and PKI-587, also known as PF-05212384); crizotinib (PF-02341066), an ALK inhibitor that also inhibits c-MET; and PF-04605412, an anti-α5β1 inhibitor.
Misonix, Inc., a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, has entered into a new, three year distribution agreement with Varlix Mexico, S.A. de C.V., based in Mexico City, Mexico, for the distribution of the SonaStar(TM) Ultrasonic Surgical Aspirator and the BoneScalpel(TM) Ultrasonic Bone Cutter. The agreement provides Varlix with the rights to sell exclusively in Mexico and includes minimum purchase requirements.
› Verified 5 days ago
Alexandra Flanick, PCE-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1835 Savoy Dr, Suite 100, Atlanta, GA 30341 Phone: 678-298-9484 Fax: 678-826-4033 | |
Mrs. Maria Thereza Barbosa, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1890 Harts Mill Rd Ne, Atlanta, GA 30341 Phone: 561-901-6310 | |
Amanda Zito Griffin, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5825 Glenridge Dr Ne, Bldg 1, Suite 133, Atlanta, GA 30328 Phone: 404-513-3810 Fax: 404-902-5440 | |
Ms. Anna Gardiner Johnson, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1872 Colt Dr # 2, Atlanta, GA 30341 Phone: 404-825-0409 | |
Anna Jane Streetman, M.ED, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 336 W Wieuca Rd Ne, Atlanta, GA 30342 Phone: 706-614-4808 | |
Jenna Mattox, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1224 N Highland Ave Ne, Unit 2, Atlanta, GA 30306 Phone: 540-314-8892 |